Precision Medical Sciences is an international and peer-reviewed open access journal that covers all areas of clinical and translational research for precision medicine, especially in the field of oncology.

The journal publishes basic and clinical trials studies which aim to promote personalized medicine, including novel technologies of cancer diagnosis, new drugs and molecule-targeted agents evaluation, innovative tumor therapy and research on pharmacology and mechanisms of oncogenesis, progression and metastasis of malignant cancers.

Journal Metrics

  • 0.6Journal Impact Factor
  • 82%Acceptance rate
  • 77 days Submission to first decision
view all metrics

Why publish in Precision Medical Sciences?

  • Your research will be free to access, making it available to read, download and share with ease.
  • Quality guaranteed with prominent, international Editorial Board and rigorous and fair peer review.
  • Your work will be discoverable and widely distributed in the biomedical fields with content indexed by Embase and Scopus
  • Published in partnership with Jiangsu Cancer Hospital, China.

Submit your paper here
    

Skip slideshow

Articles

ORIGINAL ARTICLE
Open access

Qualitative study on occupational anxiety among young thyroid cancer survivors before returning to work

  •  2 July 2025

Graphical Abstract

Qualitative study on occupational anxiety among young thyroid cancer survivors before returning to work Issue ,

The main aim of this study was to elucidate and clarify the manifestations of occupational anxiety among young postoperative thyroid cancer survivors before returning to work and to explore strategies and support needed to cope upon their return to work.

ORIGINAL ARTICLE
Open access

P53 and anti-p53 autoantibody complex versus anti-p53 antibody as a biomarker for gastrointestinal cancer

  •  18 June 2025

Graphical Abstract

P53 and anti-p53 autoantibody complex versus anti-p53 antibody as a biomarker for gastrointestinal cancer Issue ,

This study compares the diagnostic value of the anti-p53 autoantibody as potential biomarkers for gastrointestinal cancer with enzyme-linked immunosorbent assay technique.

ORIGINAL ARTICLE
Open access

Hypericin and resveratrol anti-tumor impact through E-cadherin, N-cadherin, galectin-3, and BAX/BCL-ratio; possible cancer immunotherapy succor on Y79 retinoblastoma cells

  •  11 June 2025

Graphical Abstract

Hypericin and resveratrol anti-tumor impact through E-cadherin, N-cadherin, galectin-3, and BAX/BCL-ratio; possible cancer immunotherapy succor on Y79 retinoblastoma cells Issue ,

Hypericin and Resveratrol can be proposed as beneficial accompanying reagents in cancer immunotherapy and retinoblastoma treatment.

ORIGINAL ARTICLE
Open access

Application of family‐based dignity therapy program in primary caregivers of advanced cancer patients

  •  18 April 2025

Graphical Abstract

Application of family-based dignity therapy program in primary caregivers of advanced cancer patients Issue ,

This study applied family-based dignity therapy (FBDT) to patients with advanced cancer and their primary caregivers to explore the impact of FBDT on the psychological status of primary caregivers and family functioning.

ORIGINAL ARTICLE
Open access

Visualization and hotspot analysis of CAR-T research based on CiteSpace

  •  85-93
  •  9 April 2025

Graphical Abstract

Visualization and hotspot analysis of CAR-T research based on CiteSpace Issue 2, 2025

Articles on CAR-T cells were collected from the Web of Science Core Collection (WoSCC). Key bibliometric characteristics were analyzed using CiteSpace. Our findings showed that CAR-T cell therapy is a cutting-edge field that has drawn a lot of interest, that its depth and excitement for research are growing, and that it may face further challenges and opportunities in the future.

REVIEW ARTICLE
Open access

Recent innovations in machine learning for skin cancer lesion analysis and classification: A comprehensive analysis of computer‐aided diagnosis

  •  15-40
  •  17 February 2025

Graphical Abstract

Recent innovations in machine learning for skin cancer lesion analysis and classification: A comprehensive analysis of computer-aided diagnosis Issue 1, 2025

Skin cancer represents a significant health risk, underscoring the crucial need for early detection as a preventive measure. It can be difficult to determine a skin spot's potential hazard just by looking at it and feeling it, though. Recent research has examined early classification methods, including deep learning (DL) and computer vision, to address this issue. This article provides a comprehensive overview of methodologies and tools employed in skin cancer detection research over the last 6 years. The exploration encompasses the entire classification process, spanning data preprocessing, segmentation, feature extraction, feature selection, and final classification. This article has investigated diverse datasets and utilized techniques such as DL and ML in conjunction with computer vision to improve diagnostic accuracy. Despite notable achievements, challenges persist due to the diverse nature of skin lesions. This study aims to critically analyze existing approaches for diagnosing skin cancer, highlighting unresolved issues and providing insights to guide future research in refining and advancing early categorization strategies.

REVIEW ARTICLE
Open access

EGFR and JAK2 were significant master gene biomarkers in invasive and noninvasive pituitary adenoma

  •  4-14
  •  30 January 2025

Graphical Abstract

EGFR and JAK2 were significant master gene biomarkers in invasive and noninvasive pituitary adenoma Issue 1, 2025

(A) Visualization of the interactions between upregulated and downregulated genes in invasive and non-invasive pituitary adenomas, highlighting the central role of EGFR and JAK2 as master gene biomarkers. (B) Expression density plots show the distribution of gene expression values after normalization, and volcano plots illustrate significant DEGs between invasive and non-invasive conditions. (C) Boxplots display the standard deviation across all normalized samples, ensuring consistent data preprocessing for downstream analysis.

More articles
More articles
More articles

Recent issues